The Test Kit,coronavirus Detection, cataloged under National Stock Number 6550-01-688-1555, is classified within Federal Supply Class 6550 (In Vitro Diagnostic Substances, Reagents, Test Kits and Sets) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Biofire Defense Llc. Government technical data includes 4 specifications, cited from the U.S. Government catalog. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 3 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: BX.
| Parameter | Value |
|---|---|
| NSN | 6550-01-688-1555 |
| Primary Part Number | 423742 |
| Item Name | Test Kit,coronavirus Detection |
| FSC / FSG | 6550 / 65 — In Vitro Diagnostic Substances, Reagents, Test Kits and Sets |
| Manufacturer | Biofire Defense Llc |
| Status | ACTIVE |
| Test Type | CORONAVIRUS DISEASE 2019 - (COVID-19) |
| Test Media | SALIVA |
| Test Capability Quantity | 30 |
| Test Method | ANTIGEN |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | BX |
| Part Number | Manufacturer |
|---|---|
| 423742 PRIMARY | Biofire Defense Llc (USA) |
| Reference | Meaning |
|---|---|
| 423738 | 5/9 Secondary reference Biofire Defense Llc |
| 1574762 | 5/1 Secondary reference U.S. Government activity |
| 6550NCM206258 | 5/1 Secondary reference Defense Medical Standardization Board |
NSN 6550-01-688-1555 is a Test Kit,coronavirus Detection, manufactured by Biofire Defense Llc, classified under FSC 6550, In Vitro Diagnostic Substances, Reagents, Test Kits and Sets. Status: active.
NSN 6550-01-688-1555 has 1 manufacturer part number on file: 423742 (Biofire Defense Llc).
Key specifications for 423742: Test Type: CORONAVIRUS DISEASE 2019 - (COVID-19); Special Features: TEST INTENDED FOR THE SIMULTANEOUS QUALITATIVE DETECTION AND DIFFERENTIATION OF NUCLEIC ACIDS FROM MULTIPLE RESPIRATORY VIRAL AND BACTERIAL ORGANISMS, INCLUDING NUCLEIC ACID FROM THE SARS-COV-2 VIRUS, IN NASOPHARYNGEAL SWABS (NPS) OBTAINED FROM INDIVIDUALS SUSPECTED OF COVID-19 BY THEIR HEALTHCARE PROVIDER, DURING THE ACUTE PHASE OF INFECTION; 30 TESTS; FOR USE WITH BIOFIRE FILMARRAY 2.0 OR BIOFIRE FILMARRAY TORCH SYSTEMS; STORE THE TEST AND CONTROL KIT, INCLUDING REAGENT POUCHES AND PROVIDED BUFFERS, AT ROOM TEMPERATURE 15 C TO 30 C (59 F TO 86 F); DO NOT REFRIGERATE.; Test Media: SALIVA; Test Capability Quantity: 30. 4 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.